Cargando…
Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRon2 Does Not Improve the In Vitro Efficacy
The blood-stage malaria vaccine candidate Plasmodium falciparum apical membrane antigen 1 (PfAMA1) can induce strong parasite growth-inhibitory antibody responses in animals but has not achieved the anticipated efficacy in clinical trials. Possible explanations in humans are the insufficient potency...
Autores principales: | Spiegel, Holger, Boes, Alexander, Fendel, Rolf, Reimann, Andreas, Schillberg, Stefan, Fischer, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484772/ https://www.ncbi.nlm.nih.gov/pubmed/28702028 http://dx.doi.org/10.3389/fimmu.2017.00743 |
Ejemplares similares
-
Improvement of a fermentation process for the production of two PfAMA1-DiCo-based malaria vaccine candidates in Pichia pastoris
por: Kastilan, Robin, et al.
Publicado: (2017) -
PfRON3 is an erythrocyte-binding protein and a potential blood-stage vaccine candidate antigen
por: Zhao, Xin, et al.
Publicado: (2014) -
Plant-Based Production of Recombinant Plasmodium Surface Protein Pf38 and Evaluation of its Potential as a Vaccine Candidate
por: Feller, Tatjana, et al.
Publicado: (2013) -
Plant expression and characterization of the transmission-blocking vaccine candidate PfGAP50
por: Beiss, Veronique, et al.
Publicado: (2015) -
Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1
por: Maskus, Dominika J., et al.
Publicado: (2016)